PureTech Health (PRTC) Current Deferred Revenue: 2019-2021
- PureTech Health's Current Deferred Revenue fell 95.58% to $65,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $65,000, marking a year-over-year decrease of 95.58%. This contributed to the annual value of $65,000 for FY2021, which is 95.58% down from last year.
- Latest data reveals that PureTech Health reported Current Deferred Revenue of $65,000 as of Q4 2021, which was down 95.58% from $1.5 million recorded in Q4 2020.
- PureTech Health's 5-year Current Deferred Revenue high stood at $5.5 million for Q4 2019, and its period low was $65,000 during Q4 2021.
- Over the past 3 years, PureTech Health's median Current Deferred Revenue value was $1.5 million (recorded in 2020), while the average stood at $2.3 million.
- Data for PureTech Health's Current Deferred Revenue shows a maximum YoY crashed of 95.58% (in 2021) over the last 5 years.
- Over the past 3 years, PureTech Health's Current Deferred Revenue (Quarterly) stood at $5.5 million in 2019, then crashed by 73.11% to $1.5 million in 2020, then plummeted by 95.58% to $65,000 in 2021.
- Its Current Deferred Revenue stands at $65,000 for Q4 2021, versus $1.5 million for Q4 2020 and $5.5 million for Q4 2019.
